OREGANO (Delight of the Mountains”) 10 ml
Steam Distilled Origanum vulgare L. from Hungary
Natural / Kosher / Diffuser Friendly
Dilute 1:4 (GRAS)
a ratio of 5% dilution for overall use is recommended (15-30 drops per ounce), and 2.5% dilution rate for children or the elderly (15 drops to one ounce).
Note: Middle with a warm spicy, herbaceous aroma
Blends with: Lavender Rosemary, Bergamot, Cypress, Cedar Wood, Eucalyptus & Tea Tree
Common Uses: Used in ancient Greece for treating bacterial infections on the skin , in wounds & to protect food from bacteria. Respected for its antimicrobial, antibacterial, anti parasitic and anti fungal properties. Oregano essential oil provides protection against fungal and viral infections. Can help heal Psoriasis, Eczema, Athlete’s foot, & the flu. It is a hot oil that can cause irritation of the skin & mucus membranes. Coughs, digestion.
Mind: Increases your psychological wellbeing, improves moods and helps with feeling safe and secure.
Personal Note: My family mixes 4 drops of this oil in a spoonful of coconut oil when we feel that we are catching an illness. There has been a ton of research done on it's effectiveness as an anti-biotic. This is a "hot" oil and should be treated carefully. Here is one such article:
Essential Oil from Origanum vulgare Completely Inhibits the Growth of Multidrug-Resistant Cystic Fibrosis Pathogens.
, Maggini V
, Maida I
, Lo Nostro A
, Calonico C
, Sassoli C
, Perrin E
, Fondi M
, Mengoni A
, Chiellini C
, Vannacci A
, Gallo E
, Gori L
, Bogani P
, Bilia AR
, Campana S
, Ravenni N
, Dolce D
, Firenzuoli F
, Fani R
Essential oils (EOs) are known to inhibit the growth of a wide range of microorganisms. Particularly interesting is the possible use of EOs to treat multidrug-resistant cystic fibrosis (CF) pathogens. We tested the essential oil (EO) from Origanum vulgare for in vitro antimicrobial activity, against three of the major human opportunistic pathogens responsible for respiratory infections in CF patients; these are methicillin-resistant Staphylococcus aureus, Stenotrophomonas maltophilia and Achromobacter xylosoxidans. Antibiotic susceptibility of each strain was previously tested by the standard disk diffusion method. Most strains were resistant to multiple antibiotics and could be defined as multi-drug-resistant (MDR). The antibacterial activity of O. vulgare EO (OEO) against a panel of 59 bacterial strains was evaluated, with MIC and MBC determined at 24, 48 and 72 hours by a microdilution method. The OEO was effective against all tested strains, although to a different extent. The MBC and MIC of OEO for S. aureus strains were either lower or equal to 0.50%, v/v, for A. xylosoxidans strains were lower or equal to 1% and 0.50%, v/v, respectively; and for S. maltophilia strains were lower or equal to 0.25%, v/v. The results from this study suggest that OEO might exert a role as an antimicrobial in the treatment of CF infections.